Early induction of angiotensin I-converting enzyme in rat carotid artery after balloon injury

被引:21
|
作者
FernandezAlfonso, MS
Martorana, PA
Licka, I
vanEven, P
Trobisch, D
Scholkens, BA
Paul, M
机构
[1] FREE UNIV BERLIN, KLINIKUM BENJAMIN FRANKLIN, DEPT CLIN PHARMACOL & TOXICOL, D-12200 BERLIN, GERMANY
[2] UNIV COMPLUTENSE, FAC FARM, DEPT FARMACOL, E-28040 MADRID, SPAIN
[3] HOECHST MARION ROUSSEL, PHARMA FORSCH HMR TD, CARDIOVASC AGENTS, FRANKFURT, GERMANY
关键词
angiotensin-converting enzyme inhibitors; angiotensin-converting enzyme; balloon injury; polymerase chain reaction;
D O I
10.1161/01.HYP.30.2.272
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Several studies have demonstrated the effectiveness of angiotensin I-converting enzyme (ACE) inhibitors in preventing the neointima formation found after denudation of the rat carotid artery by balloon injury. The aim of the present study was to determine the role of ACE in this model and to compare the treatment with the ACE inhibitor ramiprilat with that with the angiotensin II antagonist HR 720. The endothelial laver of the left carotid artery was removed using an inflated balloon cathetcr. Injured and control vessels were both submitted to histomorphological analysis and DNA content quantification at 2, 4, 6, 8, 12, and 14 days after injury. Evaluation of neointima thickening demonstrated a slow bur steady increase of neointima that was significant after day 6 and reached 30% of the lumen in 2 weeks. This was paralleled by an increase in DNA content, which was significant 4 days after injury. ACE mRNA levels were quantified by polymerase chain reaction after reverse transcription. Measurement of ACE mRNA levels revealed a significant upregulation 2,and 8 days after injury, with no significant difference when compared with control tissue at later time points. ACE activity was also significantly enhanced at 2 and 8 days after injury, with no significant difference when compared with control tissue at later time points. In addition, the treatment with ramiprilat was more efficient in reducing neointima. formation than that with HR 720. These data underlie the role of ACE in this model of restenosis. The early induction of ACE expression after endothelial injury but before significant changes in the vessel structure suggests that ACE activity might be one of the mechanisms that trigger neointima formation in the rat.
引用
收藏
页码:272 / 277
页数:6
相关论文
共 50 条
  • [21] EFFECT OF PERINDOPRIL, AN INHIBITOR OF ANGIOTENSIN-CONVERTING ENZYME (ACE), ON MYOINTIMAL PROLIFERATION INDUCED BY BALLOON INJURY IN RAT CAROTID-ARTERY
    JANIAK, P
    PILLON, A
    VILAINE, JP
    FASEB JOURNAL, 1992, 6 (04): : A1040 - A1040
  • [22] Mice lacking endothelial angiotensin I-converting enzyme have increased intrarenal angiotensin I-converting enzyme 2 protein abundance
    Juretzko, A.
    Steinbach, A.
    Lendeckel, U.
    Rettig, R.
    ACTA PHYSIOLOGICA, 2017, 219 : 119 - 121
  • [23] Association of angiotensin I-converting enzyme gene polymorphism with susceptibility to antiproteinuric effect of angiotensin I-converting enzyme inhibitors in patients with proteinuria
    Moriyama, T
    Kitamura, H
    Ochi, S
    Izumi, M
    Yokoyama, K
    Yamauchi, A
    Ueda, N
    Kamada, T
    Imai, E
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (06): : 1674 - 1678
  • [24] DIFFERENTIAL DISTRIBUTION OF ANGIOTENSIN I-CONVERTING ENZYME IN NORMAL AND HYPERTENSIVE RAT KIDNEYS
    VIO, CP
    ALHENCGELAS, F
    HYPERTENSION, 1995, 25 (06) : 1371 - 1371
  • [25] DIFFERENTIAL DISTRIBUTION OF ARTERIAL ANGIOTENSIN I-CONVERTING ENZYME IN SPONTANEOUSLY HYPERTENSIVE RAT
    GOTOH, M
    MIZUNO, K
    FUKUCHI, S
    JAPANESE HEART JOURNAL, 1984, 25 (05): : 875 - 875
  • [26] Angiotensin I-converting enzyme activity in tubular fluid along the rat nephron
    Casarini, DE
    Boim, MA
    Stella, RCR
    KriegerAzzolini, MH
    Krieger, JE
    Schor, N
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1997, 272 (03) : F405 - F409
  • [27] Angiotensin I-converting enzyme in cerebrospinal fluid and neurosarcoiclosis
    Baudin, B
    Bénéteau-Burnat, B
    Vaubourdolle, M
    ANNALES DE BIOLOGIE CLINIQUE, 2005, 63 (05) : 475 - 480
  • [28] Angiotensin I-converting enzyme - Genotype and disease associations
    Crisan, D
    Carr, J
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2000, 2 (03): : 105 - 115
  • [29] Dipeptide Inhibitors of Thermolysin and Angiotensin I-Converting Enzyme
    Khan, Mahmud Tareq Hassan
    Dedachi, Kenichi
    Matsui, Toshiro
    Kurita, Noriyuki
    Borgatti, Monica
    Gambari, Roberto
    Sylte, Ingebrigt
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2012, 12 (16) : 1748 - 1762
  • [30] Tissue Specificity of Human Angiotensin I-Converting Enzyme
    Kryukova, Olga V.
    Tikhomirova, Victoria E.
    Golukhova, Elena Z.
    Evdokimov, Valery V.
    Kalantarov, Gavreel F.
    Trakht, Ilya N.
    Schwartz, David E.
    Dull, Randal O.
    Gusakov, Alexander V.
    Uporov, Igor V.
    Kost, Olga A.
    Danilov, Sergei M.
    PLOS ONE, 2015, 10 (11):